Haemonetics Corporation (HAE) stock news · rev $1.33B
Haemonetics Corporation (HAE) is a medical devices company listed on US.
This HAE news page leads with what Haemonetics Corporation filed — not a scraped headline mill.
No cached 8-K sentence for HAE yet. We will not pad this page with generic market recap.
Latest reported HAE revenue for 2026-03-28 was $1.33B. Net income was $97.3M. Revenue was down 2.0% from 2025-03-29 to 2026-03-28. HAE currently screens at market cap $3.24B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the HAE stock page; for the tape open the quote page.
HAE stock news FAQ
What are HAE's latest revenue and net income?
Latest cached Haemonetics Corporation (HAE) revenue for Mar 28, 2026 was $1.33B. Net income was $97.3M. Statements: https://lician.com/financials/hae
How did HAE revenue change from the prior cached period?
Cached Haemonetics Corporation (HAE) revenue was down 2.0% from $1.36B (Mar 29, 2025) to $1.33B (Mar 28, 2026). Statements: https://lician.com/financials/hae
What is HAE's market cap?
Haemonetics Corporation (HAE) market cap is $3.24B on the latest cached fundamentals snapshot.
What kind of company is HAE?
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Where is HAE stock news listed?
Cached stock news for Haemonetics Corporation (HAE) is listed at https://lician.com/news/hae. Filings: https://lician.com/sec/hae
Not investment advice.